Reuters logo
BRIEF-RaQualia Pharma gets substance patent for ghrelin receptor agonist(serine derivative) in Japan
October 6, 2016 / 4:16 AM / a year ago

BRIEF-RaQualia Pharma gets substance patent for ghrelin receptor agonist(serine derivative) in Japan

Oct 6 (Reuters) - RaQualia Pharma Inc :

* Says it received substance patent for ghrelin receptor agonist(serine derivative) in Japan

* Says the substance is used for improvement of anorexia and suppression of body weight reduction

Source text in Japanese:goo.gl/QRT4mA

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below